Legal & General Group Plc - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q1 2022$6,000
-53.8%
3,0090.0%0.00%–
Q4 2021$13,000
-53.6%
3,0090.0%0.00%–
Q3 2021$28,000
-36.4%
3,009
+23.3%
0.00%–
Q2 2021$44,000–2,441–0.00%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders